medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2017, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2017; 15 (1)

Nasal Type nk/t Cell Lymphoma Extranasal Variant. A Case Report and eview

López VF, Aquino FC, Sibaja NL, Aquino JMÁ, Toussaint CS, Arenas GR

Language: Spanish
References: 29
Page: 22-25
PDF size: 206.69 Kb.


ABSTRACT

nk/t cell lymphoma is a rare tumor, with a varied clinical presentation. When skin is involved, clinical manifestations include: indurated plaques, tumors, subcutaneous nodules, and others. Opportune diagnosis and management are mandatory since it is an aggressive condition. We report a 69 year-old man with three dome shape ulcerated tumors, with necrotic center, and peritumoral infiltration. Diagnosis of nk/t lymphoma was performed by immuno-histochemical phenotyping methods and histopathology. After eight cycles of chemotherapy complete healing of cutaneous lesions was observed, with recurrence and fatal outcome after four months free of disease.


REFERENCES

  1. Sareeta R, Parker S, Solomon A y Lane J. Report of Epstein-Barr viruspositive primary cutaneous natural killer/t-cell lymphoma, J Am Acad Dermatol 2008; 59(1): 157-61.

  2. Jo J, Yoon DH, Kim S et al. Clinical features and prognostic model for extranasal nk/t-cell lymphoma, Eur J Haematol 2012; 89(2): 103-10.

  3. Lin N, Song Y, Zheng W et al. A prospective phase ii study of L-asparaginase- chop plus radiation in newly diagnosed extranodal nk/t-cell lymphoma, nasal type, J Hematol Oncol 2013; 6: 44.

  4. Aozasa K y Zaki M. Epidemiology and pathogenesis of nasal nk/t-cell lymphoma: a mini-review, Scientific World Journal 2011; 11: 422-8.

  5. Chan JK, Sin VC, Wong KF et al. Non nasal lymphomas expressing the natural killer cell marker cd56: a clinic pathologic study of 49 cases of uncommon aggressive neoplasm, Blood 1997; 89(12): 4501-13.

  6. Rodrigo JP, Suárez C, Rinaldo A et al. Idiopathic midline destructive disease: factor fiction, Oral Oncol 2005; 41(4): 340-8.

  7. Altemani A, Barbosa AC, Kulka M et al. Characteristics of nasal t/nkcell lymphoma among Brazilians, Neoplasma 2002; 49(1): 55-60.

  8. Arber DA, Weiss LM, Albújar PF et al. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection, Am J Surg Pathol 1993; 17(4): 392-9.

  9. Jaffe E, Krenacs L y Raffeld M. Classification of cytotoxic t-cell and natural killer cell lymphomas, Semin Hematol 2003; 40(3): 175-84.

  10. Barrionuevo C, Zaharia M, Martínez MT et al. Extranodal nk/t-cell lymphoma, nasal type: study of clinic pathologic and prognosis factors in a series of 78 cases from Peru, Applimmunohistochem Mol Morphol 2007; 15(1): 38-44.

  11. Willemze R, Jaffe E, Burg G et al. who-eortc classification for cutaneous lymphomas, Blood 2005; 105(10): 3768-85.

  12. Rueda J y Cortés C. Linfomas cutáneos, Rev Asoc Col Dermatol 2008; 16(2): 143-58.

  13. Takahashi E, Asano N, Li C et al. Nodal t/nk-cell lymphoma of nasal type: a clinic pathological study of six cases, Histopathology 2008; 52(5): 585-96.

  14. Vázquez A, Khan MN, Blake DM et al. Extranodal natural killer/t-cell lymphoma: a population-based comparison of sinonasal and extranasal disease, Laryngoscope 2014; 124(4): 888-95.

  15. Zhang T, Fu Q, Gao D et al. ebv associated lymphomas in 2008 who classification, Pathol Res Pract 2014; 210(2): 69-73.

  16. Garrido F, Festenstein H y Schirrmacher V. Further evidence for depression of h-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines, Nature 1976; 261(5562): 705-7.

  17. Yu JB, Zuo Z, Tang Y et al. Extranodal nasal-type natural killer/t-cell lymphoma of the skin: a clinic pathologic study of 16 cases in China, Hum Pathol 2009; 40(6): 807-16.

  18. Pol-Rodríguez MM, Fox LP, Sulis ML et al. Extranodal nasal-type natural killer T-cell lymphoma in an adolescent from Bangladesh, J Am Acad Dermatol 2006; 54(5 Suppl): S192-7.

  19. Greer JP, Kinney MC y Loughran TP Jr. T-cell and nk-cell lympho proliferative disorders, Hematology Am Soc Hematol Educ Program 2001; 2001(1): 259-81.

  20. Quintanilla-Martínez L, Kremer M, Keller G et al. p53 mutations in nasal. Natural killer/t-cell lymphoma from Mexico, Am J Pathol 2001; 159(6): 2095-105.

  21. Lee J, Suh C, Park YH et al. Extranodal natural killer t-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study, J Clin Oncol 2006; 24(4): 612-8.

  22. Anderson JR, Armitage JO y Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations, Ann Oncol 1998; 9(7): 717-20.

  23. Au WY, Weisenburger DD, Intragumtornchai T et al. Clinical differences between nasal and extranasal natural killer/t-cell lymphoma: a study of 136 cases from the International Peripheral t-cell lymphoma Project, Blood 2009; 113(17): 3931-7.

  24. Kojya S, Matsumura J, Ting L et al. Familial nasal nk/t-cell lymphoma and pesticide use, Am J Hematol 2001; 66(2): 145-7.

  25. Waterhouse D, Carman WJ, Schottenfeld D et al. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lympho poietic neoplasms, Cancer 1996; 77(4): 763-70.

  26. Bajor-Dattilo EB, Pittaluga S y Jaffe ES. Pathobiology of t-cell and nk-cell lymphomas, Best Pract & Res Clin Haematol 2013; 26(1): 75-87.

  27. Lan MX, Zhen ZX y Ming WH. cd56-negative extranodal nasal type of natural killer/t-cell lymphoma with extranasal skin involvement, Leuk Lymphoma 2009; 50(10): 1715-7.

  28. Quintanilla-Martínez L, Franklin JL, Guerrero I et al. Histological and immunophenotypic profile of nasal nk/t-cell lymphomas from Peru: high prevalence of p53 over expression, Hum Pathol 1999; 30(7): 849-55.

  29. Miles RR, Afify Z, Yaish H y Perkins SL. cd56-negative extranodal nasal type nk/t-cell lymphoma, Pediatr Blood Cancer 2010; 55(1): 186-9.




2020     |     www.medigraphic.com